Home Prescription Drugs Tags

View the Latest: Prescription Drugs

Filter

List Grid

801-807 of 807 results

  • As ACA Deadline Approaches, Some Price-Sensitive Consumers May Consider Switching to Short-Term Plans

    Quick Insights

    As the ACA open enrollment deadline approaches amid the expiration of the enhanced premium tax credits, nearly six in 10 Marketplace enrollees say they would not be able to afford $300 more in annual health care costs, which may lead some to alternative coverage products, such as short-term plans, a type of private coverage that tends to have lower premiums but few consumer protections and limited benefits.

  • Workers Now Pay $7,471 on Average Annually for Family Health Coverage, Up 9% or $621 from 2025, Benchmark Employer Health Benefits Survey Finds

    News Release

    Workers are paying on average $7,471 annually toward the premiums for employer-sponsored family health benefits this year, which is up 9%, or $621, from 2025, per KFF’s annual benchmark health benefits survey of large and small employers. The burden of family premiums hits particularly hard for workers at small firms with less than 200 workers. On average, covered workers in small firms are contributing $9,687 annually toward family coverage this year. That’s $2,847 more than…

  • U.S. Health Spending Is Expected to Reach $9 Trillion by 2034

    How Much is Health Spending Expected to Grow?

    Feature

    This chart collection explores how much health spending is expected to grow in the coming years, with a look at growth in prescription drug spending, out-of-pocket spending, and related trends.

  • 2026 Employer Health Benefits Survey

    Feature

    This is the 28th Employer Health Benefits Survey (EHBS) and reflects employer-sponsored health benefits in 2026. As in years past, the survey examines trends in employer coverage, including premiums, employee contributions, deductibles, offer rates, and employer practices. This year, we asked employers detailed questions about satisfaction with their health plans; coverage of GLP-1 agonists and IVF; actions taken in response to projected cost increases; and firms’ ability to obtain information about health care costs and…